Detailed Information

Cited 25 time in webofscience Cited 32 time in scopus
Metadata Downloads

Combinatorial nanodiamond in pharmaceutical and biomedical applications

Authors
Lim, Dae GonPrim, Racelly EnaKim, Ki HyunKang, EunahPark, KinamJeong, Seong Hoon
Issue Date
Nov-2016
Publisher
ELSEVIER SCIENCE BV
Keywords
Nanodiamond; Drug delivery; Surface; Complex formation
Citation
INTERNATIONAL JOURNAL OF PHARMACEUTICS, v.514, no.1, pp 41 - 51
Pages
11
Journal Title
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume
514
Number
1
Start Page
41
End Page
51
URI
https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/6434
DOI
10.1016/j.ijpharm.2016.06.004
ISSN
0378-5173
1873-3476
Abstract
One of the newly emerging carbon materials, nanodiamond (ND), has been exploited for use in traditional electric materials and this has extended into biomedical and pharmaceutical applications. Recently, NDs have attained significant interests as a multifunctional and combinational drug delivery system. ND studies have provided insights into granting new potentials with their wide ranging surface chemistry, complex formation with biopolymers, and combination with biomolecules. The studies that have proved ND inertness, biocompatibility, and low toxicity have made NDs much more feasible for use in real in vivo applications. This review gives an understanding of NDs in biomedical engineering and pharmaceuticals, focusing on the classified introduction of ND/drug complexes. In addition, the diverse potential applications that can be obtained with chemical modification are presented. (C) 2016 Elsevier B.V. All rights reserved.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Engineering > School of Chemical Engineering and Material Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kang, Eunah photo

Kang, Eunah
공과대학 (화학공학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE